1 Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Nov 13, 2024
Read More Apparatus The Frontier Drug INT230-6 Has Shown Promising Therapeutic Results In Soft Tissue Sarcoma! Nov 04, 2024
Read More Apparatus Genkore Announces Collaboration With Us Company On In Vivo Gene Editing Therapies Nov 16, 2024
Read More Apparatus Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Nov 13, 2024
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Nov 17, 2024
